Insider · CIK 0001917165
Arye Barak Ben
Files at NVCR (NovoCure Ltd). First filing -, latest -.
In brief
Arye Barak Ben files SEC Form 4 as officer at NVCR (NovoCure Ltd). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Arye Barak Ben has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | NVCR NovoCure Ltd | AGrant or award Ordinary Shares | +1,299 | $11.15 | $14k | 243,752 | Jul 1, 2026 |
| Mar 3, 2026 | NVCR NovoCure Ltd | AGrant or award Ordinary Shares | +50,125 | $0.00 | $0 | 242,453 | Mar 5, 2026 |
| Mar 3, 2026 | NVCR NovoCure Ltd | AGrant or award Stock Option (Right to Buy)derivative | +73,340 | $0.00 | $0 | 73,340 | Mar 5, 2026 |
| Feb 28, 2026 | NVCR NovoCure Ltd | AGrant or award Ordinary Shares | +17,755 | $0.00 | $0 | 192,328 | Mar 3, 2026 |
| Jun 30, 2025 | NVCR NovoCure Ltd | AGrant or award Ordinary Shares | +769 | $15.13 | $12k | 174,465 | Jul 1, 2025 |
| Mar 4, 2025 | NVCR NovoCure Ltd | AGrant or award Ordinary Shares | +54,975 | $18.19 | $1000k | 173,696 | Mar 6, 2025 |
| Mar 4, 2025 | NVCR NovoCure Ltd | AGrant or award Stock Options (Right to buy)derivative | +81,499 | $18.19 | $1.5M | 81,499 | Mar 6, 2025 |
| Dec 31, 2024 | NVCR NovoCure Ltd | AGrant or award Ordinary Shares | +669 | $14.75 | $9,866 | 118,721 | Jan 3, 2025 |
| Dec 31, 2023 | NVCR NovoCure Ltd | AGrant or award Ordinary Shares | +128 | $12.69 | $1,624 | 35,323 | Feb 29, 2024 |
| Feb 27, 2024 | NVCR NovoCure Ltd | AGrant or award Ordinary Shares | +81,799 | $16.30 | $1.3M | 117,122 | Feb 29, 2024 |
| Feb 27, 2024 | NVCR NovoCure Ltd | AGrant or award Stock Options (Right to buy)derivative | +125,078 | $16.30 | $2.0M | 125,078 | Feb 29, 2024 |
Questions about Arye Barak Ben
Answered from the filings on this page, as of the latest one.
Is Arye Barak Ben buying or selling?
Arye Barak Ben has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Arye Barak Ben's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Arye Barak Ben has 0.
Where does Arye Barak Ben file Form 4?
Arye Barak Ben has filed Form 4 at NVCR (NovoCure Ltd) as General Counsel. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.